TRANSLOCATION RENAL CELL CARCINOMA
Clinical trials for TRANSLOCATION RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSLOCATION RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSLOCATION RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat attack on advanced kidney cancer begins human testing
Disease control Recruiting nowThis study is testing a new combination of three drugs to see if they can safely control advanced kidney cancer that has spread. The trial will enroll about 25 adults with specific types of advanced kidney cancer who have not yet received treatment for their metastatic disease. R…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
First-in-Human trial tests 'Memory-Like' immune cells to fight tough cancers
Disease control Recruiting nowThis is a very early, small study to see if a new type of immune cell therapy is safe and possible to give to people. It will test a treatment made from a patient's own 'natural killer' immune cells, which are collected and specially prepared in a lab to potentially fight cancer.…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New drug duo tested for Tough-to-Treat kidney cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, abemaciclib and cabozantinib, is safe and effective for people with advanced kidney cancer that has spread and has stopped responding to standard treatments. Researchers will first find the safest dose and then see how well the c…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 02, 2026 15:21 UTC